Padagis
FDA Inspections Database
Padagis
FDA Inspections Database
U.S. FDA inspection classifications and citation records from the official FDA inspection database.
- Total Records 11
- Latest Inspection 2024-09-06
- Data Source U.S. FDA
- Last Updated 2024-11-13
Company Overview
Social Profiles
Company Snapshot
Padagis
Zvi Bornstein str. PO Box: 80500 Old Industrial Park, Yerucham 16
Israel
padagis.com/ View on MapFDA Inspections Timeline (11 records)
Legal Name
Padagis US LLC
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
Yes
Inspection End Date
2024-09-06
FMD Date
2024-11-13
Fiscal Year
2024
State
Minnesota
Location
Minneapolis, Minnesota, United States
Inspection Info
Fiscal Year: 2024
Citations: Yes
Legal Name
Padagis US LLC
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2024-01-31
FMD Date
2024-04-17
Fiscal Year
2024
State
Minnesota
Additional Details
Postmarket Adverse Drug Experience (PADE)
Location
Minneapolis, Minnesota, United States
Inspection Info
Fiscal Year: 2024
Citations: No
Legal Name
Padagis US LLC
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2023-05-05
FMD Date
2024-05-07
Fiscal Year
2023
State
Minnesota
Additional Details
Bioanalytical BA/BE
Location
Minneapolis, Minnesota, United States
Inspection Info
Fiscal Year: 2023
Citations: No
Legal Name
Padagis US LLC
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
Yes
Inspection End Date
2022-02-18
FMD Date
2022-04-22
Fiscal Year
2022
State
Minnesota
Location
Minneapolis, Minnesota, United States
Inspection Info
Fiscal Year: 2022
Citations: Yes
Legal Name
Padagis US LLC
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2019-10-23
FMD Date
2020-05-06
Fiscal Year
2020
State
Minnesota
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)
Location
Minneapolis, Minnesota, United States
Inspection Info
Fiscal Year: 2020
Citations: No
Legal Name
Padagis US LLC
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2017-07-07
FMD Date
-
Fiscal Year
2017
State
Minnesota
Location
Minneapolis, Minnesota, United States
Inspection Info
Fiscal Year: 2017
Citations: No
Legal Name
Padagis US LLC
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2013-11-06
FMD Date
-
Fiscal Year
2014
State
Minnesota
Location
Minneapolis, Minnesota, United States
Inspection Info
Fiscal Year: 2014
Citations: No
Legal Name
Padagis US LLC
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2013-02-06
FMD Date
-
Fiscal Year
2013
State
Minnesota
Additional Details
Postmarket Adverse Drug Experience (PADE)
Location
Minneapolis, Minnesota, United States
Inspection Info
Fiscal Year: 2013
Citations: No
Legal Name
Padagis US LLC
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2013-02-06
FMD Date
-
Fiscal Year
2013
State
Minnesota
Location
Minneapolis, Minnesota, United States
Inspection Info
Fiscal Year: 2013
Citations: No
Legal Name
Padagis US LLC
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2010-11-19
FMD Date
-
Fiscal Year
2011
State
Minnesota
Location
Minneapolis, Minnesota, United States
Inspection Info
Fiscal Year: 2011
Citations: No
Legal Name
Padagis US LLC
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2009-03-20
FMD Date
-
Fiscal Year
2009
State
Minnesota
Location
Minneapolis, Minnesota, United States
Inspection Info
Fiscal Year: 2009
Citations: No
Classification Breakdown
11 total- VAI (Voluntary Action Indicated)
- NAI (No Action Indicated)
Official Source
All data is sourced from the official FDA inspection database maintained by the U.S. Food and Drug Administration.
Visit FDA.govRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Location
Minneapolis, Minnesota, United States
Inspection Info
Fiscal Year: 2024
Citations: Yes
100% Official Data
Directly from the U.S. FDA inspection database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.